Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.
Apr 20, 2015
0
106
Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...
Nov 30, 2018
0
9
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.
Oct 20, 2017
0
0
(Medical Xpress)—To move material in bulk, the standard shipping container used by cells, is the vesicle. These approximately 40-micron sized spheres are essentially recyclable grocery bags that can be loaded and adorned ...
Arrowhead Pharmaceuticals today announced results from studies of ARC-520, a prior-generation RNAi therapeutic candidate against chronic hepatitis B virus (HBV) infection, in a Phase 2 clinical study in HBV patients and a ...
Sep 27, 2017
0
3
Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines, more than 250 million individuals worldwide are chronically infected ...
Aug 13, 2020
0
4
Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is another, less commonly known ...
Jun 16, 2022
0
8
Exciting new data presented today at the International Liver Congress 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for ...
Apr 25, 2013
0
0
Exposure to Hepatitis B virus (HBV) in utero can help 'mature' a human neonatal immune system and may improve the capacity of human neonatal immune cells to respond to secondary infections, an international research team ...
Nov 4, 2015
0
18
Scientists at UCL have significantly boosted the effectiveness of a therapeutic vaccine designed to control chronic hepatitis B (HBV) infection, after uncovering and thwarting 'the enemy within'.
Apr 13, 2022
0
62
